| Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms M Lagging, G Askarieh, F Negro, S Bibert, J Söderholm, J Westin, M Lindh, ... PloS one 6 (2), e17232, 2011 | 192 | 2011 |
| In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and … G Ahlén, J Söderholm, T Tjelle, R Kjeken, L Frelin, U Höglund, ... The Journal of Immunology 179 (7), 4741-4753, 2007 | 182 | 2007 |
| Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine HS Gill, J Söderholm, MR Prausnitz, M Sällberg Gene therapy 17 (6), 811-814, 2010 | 177 | 2010 |
| Systemic and intrahepatic interferon‐gamma‐inducible protein 10 kDa predicts the first‐phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic … G Askarieh, Å Alsiö, P Pugnale, F Negro, C Ferrari, AU Neumann, ... Hepatology 51 (5), 1523-1530, 2010 | 151 | 2010 |
| Relation between viral fitness and immune escape within the hepatitis C virus protease J Söderholm, G Ahlen, A Kaul, L Frelin, M Alheim, C Barnfield, ... Gut 55 (2), 266-274, 2006 | 126 | 2006 |
| Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo L Frelin, M Alheim, A Chen, J Söderholm, B Rozell, C Barnfield, ... Gene therapy 10 (8), 686-699, 2003 | 96 | 2003 |
| Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine JM Luke, GG Simon, J Söderholm, JS Errett, JT August, M Gale Jr, ... Journal of virology 85 (3), 1370-1383, 2011 | 95 | 2011 |
| IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1 M Lindh, M Lagging, B Arnholm, A Eilard, S Nilsson, G Norkrans, ... Journal of viral hepatitis 18 (7), e325-e331, 2011 | 69 | 2011 |
| Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia A Martner, FB Thoren, J Aurelius, J Söderholm, M Brune, K Hellstrand Expert review of hematology 3 (4), 381-391, 2010 | 49 | 2010 |
| Higher risk of renal disease in chronic hepatitis C patients: antiviral therapy survival benefit in patients on hemodialysis J Söderholm, C Millbourn, K Büsch, J Kövamees, R Schvarcz, K Lindahl, ... Journal of Hepatology 68 (5), 904-911, 2018 | 45 | 2018 |
| Frequent loss to follow‐up after diagnosis of hepatitis C virus infection: A barrier towards the elimination of hepatitis C virus S Aleman, J Söderholm, K Büsch, J Kövamees, AS Duberg Liver International 40 (8), 1832-1840, 2020 | 37 | 2020 |
| Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model X Shen, J Söderholm, F Lin, G Kobinger, A Bello, DA Gregg, KE Broderick, ... Vaccine 30 (48), 6946-6954, 2012 | 33 | 2012 |
| Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination A Chen, G Ahlén, ED Brenndörfer, A Brass, F Holmström, M Chen, ... The Journal of Immunology 186 (9), 5107-5118, 2011 | 26 | 2011 |
| Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden K Büsch, J Waldenström, M Lagging, S Aleman, O Weiland, J Kövamees, ... Scandinavian Journal of Gastroenterology 52 (1), 61-68, 2017 | 20 | 2017 |
| Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production ED Brenndörfer, A Brass, J Söderholm, L Frelin, S Aleman, JG Bode, ... Gut 61 (4), 589-596, 2012 | 20 | 2012 |
| A complete mutational fitness map of the hepatitis C virus nonstructural 3 protease: relation to recognition by cytotoxic T lymphocytes J Söderholm, M Sällberg The Journal of infectious diseases 194 (12), 1724-1728, 2006 | 17 | 2006 |
| Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection J Söderholm, J Waldenström, G Askarieh, M Pilli, PY Bochud, F Negro, ... PloS one 8 (2), e56991, 2013 | 14 | 2013 |
| DITTO-HCV and NORDynamIC Study Groups. Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall … G Askarieh, A Alsiö, P Pugnale, F Negro, C Ferrari, AU Neumann, ... Hepatology 51 (5), 1523-30, 2010 | 13 | 2010 |
| Hepatitis C outreach project and cross-sectional epidemiology in high-risk populations in Trondheim, Norway R Hannula, J Söderholm, T Svendsen, M Skaland, SA Nordbø, H Steinum, ... Therapeutic Advances in Infectious Disease 8, 20499361211053929, 2021 | 8 | 2021 |
| Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens A Vasanthakumar, JW Davis, M Abunimeh, J Söderholm, J Zha, ... Plos one 13 (5), e0198296, 2018 | 5 | 2018 |
